This is consistent with prior studies showing that a KOR antagonist (nor-BNI) in the right CeA decreased CRF output signaling and emotional responses, anxiety-like behaviors, and hypersensitivity in a functional pain model [27] and relieved aversiveness, but not hypersensitivity, in a neuropathic pain model [26]. This evidence concerns the gene OPRK1 and Anxiety.